Furthermore, a number of in vitro and in vivo prostate cancer models, including LNCaP cell lines expressing wild-type or mutated AR, have shown that radiation therapy upregulates AR signaling in CRPC, leading to radioresistance [22]. This evidence concerns the gene AR and prostate cancer.